CACI International Inc (CACI) Stock Price & Analysis
CACI International Inc (CACI) closed at USD 619.22 on Thursday, October 22, 2026, down 0.67% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 623.38; the Oct 22, 2026 session ranged USD 609.32–640.89 on volume of 433,921 shares. Market capitalization is $13.68B, with a 52-week range of USD 434.7–683.5 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:49 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CACI.md
Latest Earnings Results (CACI)
CACI International Inc (CACI) reported Q1 2027 results on Oct 21, 2026, 4:45:47 PM ET: adjusted EPS $7.66 vs. estimate $6.60 (beat), revenue $2.47B vs. estimate $2.51B (miss). Guidance: Raising fiscal year 2027 guidance for Revenue, Adjusted net income, and Adjusted EPS. Source: SEC 8-K filing. Nexqual published it 2 min 18 s after release. Read the SEC filing.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q1 2027 | $7.66 (adjusted (non-GAAP) diluted) | $2.47B | Oct 21, 2026, 4:45:47 PM ET · on Nexqual +2 min 18 s | SEC 8-K filing |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (CACI)
- Last four reported quarters (through Sep 30, 2026): revenue $9.75B, net income $541M (5.5% margin), free cash flow $776M (SEC filings).
- Valuation: P/E 25.3x (avg 21.2x at the last 3 fiscal year-ends), EV/EBITDA 17.2x, net debt $4.56B.
- Analysts: Buy (mean 2.29 on a 1–5 scale) (17 analysts), mean target USD 744.07 (range 540–925).
- Total return with dividends: 1Y +5.9% vs S&P 500 +14.9%; 5Y +117.2% vs S&P 500 +80.3%.
- Next earnings: 2027-01-20, EPS estimate USD 7.44, revenue estimate $2.54B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CACI)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $6.20B | $6.70B | $7.66B | $8.63B | $9.57B | $9.75B |
| Operating income | $496M | $568M | $650M | $764M | $920M | $955M |
| Net income | $367M | $385M | $420M | $500M | $536M | $541M |
| EPS (diluted) | $15.49 | $16.43 | $18.60 | $22.32 | $24.16 | — |
| Free cash flow | $671M | $324M | $434M | $481M | $780M | $776M |
| Operating margin | 8.0% | 8.5% | 8.5% | 8.9% | 9.6% | 9.8% |
| Net margin | 5.9% | 5.7% | 5.5% | 5.8% | 5.6% | 5.5% |
| Revenue growth | +2.6% | +8.1% | +14.3% | +12.6% | +10.9% | — |
| Cash + short-term investments | $115M | $116M | $134M | $106M | $192M | — |
| Total debt | $1.73B | $1.70B | $1.54B | $2.92B | $4.90B | — |
Fiscal years end Jun. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Sep 30, 2026) (CACI)
P/E 25.3x · P/S 1.4x · EV/EBITDA 17.2x · EV/Sales 1.9x · P/FCF 17.6x · P/B 3.0x · FCF yield 5.67% · Earnings yield 3.96% · Buyback yield (TTM) 0.13% · Net debt $4.56B · EV $18.2B
P/E at fiscal year-ends: Jun 2026 19.2x, Jun 2025 21.4x, Jun 2024 23.1x.
Analysts (CACI)
Consensus Buy (mean 2.29 on a 1–5 scale), 17 analysts; mean target USD 744.07 (low 540, high 925).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-21 | Cantor Fitzgerald | Target raised | Overweight | $675 → $785 |
| 2026-10-16 | Macquarie | Initiated | Outperform | $780 |
| 2026-10-07 | Citigroup | Target raised | Neutral | $648 → $689 |
| 2026-10-06 | BNP Paribas | Downgrade | Neutral → Underperform | $675 → $540 |
| 2026-08-11 | Citigroup | Target raised | Neutral | $519 → $648 |
| 2026-08-07 | UBS | Target raised | Buy | $598 → $804 |
| 2026-08-07 | JP Morgan | Target raised | Overweight | $645 → $715 |
| 2026-07-07 | TD Cowen | Target lowered | Buy | $625 → $550 |
| 2026-07-01 | Jefferies | Target lowered | Hold | $550 → $510 |
| 2026-07-01 | Citigroup | Target lowered | Neutral | $555 → $519 |
Total return (dividends reinvested) (CACI)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +5.9% | +117.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +6.0% | +16.7% |
| Volatility (annualized) | 38.5% | 31.1% |
| Max drawdown | -33.4% (Jan 2026→Jul 2026) | -42.5% (Nov 2024→Feb 2025) |
CACI revenue by business segment (quarter ended Sep 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Domestic | $2.40B | 96.9% | +8.5% |
| International | $76.4M | 3.1% | -1.5% |
| Total revenue | $2.47B | 100% | — |
CACI revenue by product line (quarter ended Sep 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Technology | $1.43B | 57.6% | +11.9% |
| Expertise | $972.9M | 39.3% | +3.9% |
| Total revenue | $2.47B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
CACI company outlook (results filed Oct 21, 2026)
- “The table below summarizes our fiscal year 2027 guidance and represents our views as of October 21, 2026.”
Quoted word-for-word from the SEC 8-K results press release.
CACI analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $7.44 | $7.09 | +5.0% | $2.54B | 12 |
| Next quarter (ends Mar 2027) | $8.84 | $7.69 | +14.9% | $2.75B | 12 |
| Current fiscal year (ends Jun 2027) | $33.82 | $30.82 | +9.7% | $10.79B | 14 |
| Next fiscal year (ends Jun 2028) | $38.11 | $35.22 | +8.2% | $11.50B | 15 |
CACI options: expected move
Options price a move of about ±18.8% (±$116.35) by Mar 19, 2027, which includes earnings on Jan 20, 2027; the earnings reaction alone is priced at about ±4.3%. Over the last 8 reports the stock moved ±7.6% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 37.6% | ±8.5% |
| Dec 18, 2026 | 56 | 36.1% | ±11.4% |
| Mar 19, 2027 | 147 | 37.0% | ±18.8% |
| Jun 17, 2027 | 237 | 37.0% | ±23.9% |
30-day implied volatility 36.5% vs 27.5% realized over the last 30 trading days. Put/call ratio (volume) 0.29. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:49 UTC)
| Price | USD 619.22 |
|---|---|
| Change | ▼ 0.67% (down) |
| Previous Close | USD 623.38 |
| Open | USD 627.44 |
| Day Range | USD 609.32 – 640.89 |
| 52-Week Range | USD 434.7 – 683.5 |
| Volume | 433,921 shares |
| Market Cap | $13.68B |
| Exchange | NYQ |
Technical Analysis (CACI)
Nexqual's technical model rates CACI "BUY" based on 4 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 09:49 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 52.09 (neutral) |
| vs SMA50 | Below (USD 624.24) |
| MACD | 0.2 (positive) |
Analyst Ratings (CACI)
Wall Street analysts rate CACI "Buy" based on 17 analysts, with a mean price target of USD 744.07 (range USD 540–925), per Nexqual as of October 23, 2026 at 09:49 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 744.07 |
| High Target | USD 925 |
| Low Target | USD 540 |
| Buy / Hold / Sell | 13 / 3 / 1 |
Earnings (CACI)
| Next Earnings Date | 2027-01-20 |
|---|---|
| EPS Estimate | USD 7.44 |
| Revenue Estimate | $2.54B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 7.66 vs est 6.57 ▲ beat |
| 2026-06-30 | USD 8.91 vs est 7.23 ▲ beat |
| 2026-03-31 | USD 7.27 vs est 6.93 ▲ beat |
| 2025-12-31 | USD 6.81 vs est 6.49 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:49 UTC.
Financials & Fundamentals (CACI)
| Total Revenue | $9.57B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +17.60% |
| Gross Margin | +33.20% |
| Operating Margin | +10.05% |
| Profit Margin | +5.60% |
| ROE | +12.82% |
| Debt / Equity | 1.21 |
| Current Ratio | 1.48 |
| Total Cash | $192.99M |
| Total Debt | $5.38B |
| Free Cash Flow (last four quarters to Sep 2026, SEC 10-Q / 10-K) | $775.96M (8.0% of revenue) |
Source: Nexqual, October 23, 2026 at 09:49 UTC.
Financial Health Score (CACI)
Nexqual rates CACI International Inc's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:49 UTC.
| Growth | Solid — Revenue +11% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 10% (last 12 months) |
| Balance Sheet | Mixed — $279M cash and investments vs $4.84B debt (Sep 2026, SEC) |
| Cash Flow | Solid — FCF $776M (last 4 quarters to Sep 2026, SEC), 8% margin |
| Efficiency | Mixed — ROE 13%, ROA 5.8% |
Ownership (CACI)
| Insider Ownership | +1.18% |
|---|---|
| Institutional Ownership | +104.67% |
| Shares Outstanding | 22.10M |
| Float | 21.83M |
| Short % of Float | +4.73% |
Source: Nexqual, October 23, 2026 at 09:49 UTC.
Leadership (CACI)
CACI International Inc is led by John S. Mengucci, President, CEO & Director, per Nexqual as of October 23, 2026 at 09:49 UTC.
| President, CEO & Director | John S. Mengucci |
|---|---|
| Executive VP, CFO, & Treasurer | Jeffrey D. MacLauchlan |
| Executive VP & COO | David Young |
| Senior VP & Chief Technology Officer | Jason Bales |
| Senior Vice President of Investor Relations | George A. Price |
Major Backers & Investors (CACI)
Notable institutional backers of CACI International Inc include Morgan Stanley, Barrow, Hanley Mewhinney & Strauss, LLC, Wellington Management, according to Nexqual as of October 23, 2026 at 09:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 5.3% |
| Barrow, Hanley Mewhinney & Strauss, LLC | 4.32% |
| Wellington Management | 3.22% |
| Victory Capital Management Inc. | 2.73% |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 2.69% |
| Boston Partners | 2.46% |
| Bank of America Corporation | 2.21% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.85% |
| Vanguard Group | 8.78% |
| State Street | 3.64% |
Source: Nexqual, October 23, 2026 at 09:49 UTC.
From CACI International Inc's Latest SEC 10-K Filing (filed 2026-08-06)
Key Strengths & Strategy (as disclosed to the SEC)
- Our contracts and subcontracts are composed of a wide range of contract types, including fixed-price, cost reimbursement, time-and-materials, Indefinite Delivery/Indefinite Quantity (IDIQ), and Government Wide Acquisition Contracts (known as GWACS) such as General Services Administration (GSA) schedule contracts.
- Headquartered in London, our International Operations provide a diverse mix of IT services and proprietary data and software products, serving commercial and government customers throughout the U.K., continental Europe, and around the world.
- Our proprietary information is protected through a combination of contractual arrangements with our employees and third parties and IP laws.
- From time to time, we are required to assert our rights against former employees or other third parties who attempt to misappropriate our proprietary and confidential information.
Legal & Regulatory Risks (Item 1A, quoted)
- We must comply with a variety of laws and regulations, and our failure to comply could cause our actual results to differ materially from those anticipated.
- Our integration of artificial intelligence and related technologies subjects us to operational and regulatory risks, and our failure to effectively manage these risks could have a material adverse effect on our financial results.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IT | Gartner, Inc. | USD 234.44 | ▲ 6.77% |
| LDOS | Leidos Holdings, Inc. | USD 134.73 | ▲ 4.26% |
| GIB | CGI Inc. | USD 82.15 | ▲ 3.24% |
| JKHY | Jack Henry & Associates, Inc. | USD 161.8 | ▲ 5.47% |
| WSE | Wise Group plc | USD 11.08 | ▲ 0.27% |
| FIS | Fidelity National Information S | USD 38.29 | ▲ 5.13% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt